| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053564A2 Quinuclidine derivatives and their use as m3 antagonists |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053547A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | WO2002053528A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001022919A3 Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | US20020091279 15R-5,6,15-trihydroxy-7,9,13-trans- 11-cis-eicosatetraenoic oracid,15R-5,14,15-trihydroxy-6,10,12-trans-8-cis-eicosatetraenoic acid, or 15-hydroxyeicosatetraenoic acid; anticarcinogenic agents |
| 07/11/2002 | US20020091273 Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091130 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | CA2433573A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | CA2431679A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221443A1 Substituted imidazolidinone derivatives |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220670A1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0812319B1 2-arylbenzazole compounds |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358062A 巨噬细胞清除剂受体拮抗剂 Macrophage scavenger receptor antagonists |
| 07/10/2002 | CN1357362A Stone-eliminating Jinyin medicine powder |
| 07/10/2002 | CN1357344A Nephrosis treating medicine and its prepn |
| 07/10/2002 | CN1357342A Nephrolithiasis treating medicine |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417214 Compounds as contraceptives |
| 07/09/2002 | US6417199 3-benzyl-benzothiophenes |
| 07/09/2002 | US6417194 Quinolines and quinazolines useful in therapy |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/04/2002 | WO2002052008A1 Novel cancer-associated genes |
| 07/04/2002 | WO2002052005A1 Novel genes and proteins encoded thereby |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051443A2 Aqueous gel comprising a gelling agent such as kappa carrageenan and at least 85 % water |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051418A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002032373A3 Estrogen receptor modulators |
| 07/04/2002 | WO2002028347A3 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/04/2002 | WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001062257A3 Bupropion metabolites and methods of their synthesis and use |
| 07/04/2002 | US20020087002 Naphthalenyl piperidines as renin inhibitors |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086904 Methods of treating affective disorders using derivatives of (-)- venlafaxine |
| 07/04/2002 | US20020086891 Substituted benzo(b)thiophenes or benzoisothiazoles which inhibit 2,3-oxidosqualene-lanosterol cyclase which is required for the biosynthesis of cholesterol, ergosterol and other sterols |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086864 Administering optically pure (S,S) enantiomer of reboxetine |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086282 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 07/04/2002 | US20020086057 For therapy of urinary incontinence |
| 07/04/2002 | US20020086037 For use in therapy of bacterial infections, cancer; in vaccines |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | DE10150312A1 New 2-(m-amino-phenylimino)-imidazolidine derivatives, are potent and selective alpha-1L agonists useful for treating bladder disorders, especially urinary incontinence |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |